Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
Healthcare & PharmaceuticalConferences

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

April 6, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner, SVP of Corp. Communication, will be presenting at the 25th Annual Needham Healthcare Conference on Tuesday, April 14, 2026, at 11:45 am ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast...

Read more
Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration
Healthcare & PharmaceuticalPartnerships

Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration

April 6, 2026 4:00 AM

Bioz, Inc., the AI-powered citation management platform for research, announced its collaboration with Vilber, a leading manufacturer of imaging and analysis systems for molecular biology and life science laboratories. Through a highly customized Bioz Badges implementation, Vilber is enhancing scientific transparency across its digital portfolio while delivering added value to both direct customers and global distributors. "Scientific...

Read more
Trimsulin Review 2026: Plant-Based GLP-1 Weight Loss Alternative or Hype?
Healthcare & PharmaceuticalAdvertorial

Trimsulin Review 2026: Plant-Based GLP-1 Weight Loss Alternative or Hype?

April 4, 2026 1:15 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. This article contains affiliate links, and a commission may be earned if a purchase is made through those links. Always consult a licensed healthcare professional before starting any new supplement or weight management program. This article is for informational purposes only and does not constitute medical advice. Always consult a licensed...

Read more
Joi + Blokes Telehealth 2026: GLP-1 Availability After the FDA Crackdown, Hormone Therapy Pricing, Labs, and What to Verify Before You Enroll
Healthcare & PharmaceuticalAdvertorial

Joi + Blokes Telehealth 2026: GLP-1 Availability After the FDA Crackdown, Hormone Therapy Pricing, Labs, and What to Verify Before You Enroll

April 3, 2026 10:10 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hormone health and weight management concerns should be evaluated by qualified healthcare professionals. Always consult a licensed healthcare provider before starting any prescription treatment. Only a licensed clinician who reviews your complete health history can determine whether any treatment is appropriate for your situation. Affiliate...

Read more
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll
Healthcare & PharmaceuticalAdvertorial

Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll

April 3, 2026 9:35 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight management and GLP-1 medication concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This...

Read more
MEDVi QUAD Reviews (2026) Safe Compound Medication with Vardenafil, Sildenafil, Tadalafil & Apomorphine for Men
Healthcare & PharmaceuticalAdvertorial

MEDVi QUAD Reviews (2026) Safe Compound Medication with Vardenafil, Sildenafil, Tadalafil & Apomorphine for Men

April 3, 2026 9:00 PM

This article is for informational purposes only and does not constitute medical advice. MEDVi QUAD is a compounded prescription medication that requires evaluation by a licensed clinician. Compounded medications are not FDA-approved as finished products, and individual suitability and risk must be determined by a qualified prescriber. Prescription approval is not guaranteed. This article contains affiliate links. If you purchase through these...

Read more
Dr. Sacha Obaid Named Among 2026 Best Doctors in Collin County
Healthcare & PharmaceuticalAwards

Dr. Sacha Obaid Named Among 2026 Best Doctors in Collin County

April 3, 2026 4:50 PM

Dr. Sacha Obaid of North Texas Plastic Surgery has been recognized as one of the 2026 Best Doctors in Collin County by D Magazine. This peer-selected honor identifies top doctors in the region through nominations and voting by fellow esteemed members of the local medical community. D Magazine contacts thousands of local physicians each year for confidential ballots, tallies votes, and vets results through an independent panel of physicians to...

Read more
OceansMD GLP-1 Program 2026: Is It Legit? Pricing, Compounded Semaglutide Facts, and What to Verify Before You Enroll
Healthcare & PharmaceuticalAdvertorial

OceansMD GLP-1 Program 2026: Is It Legit? Pricing, Compounded Semaglutide Facts, and What to Verify Before You Enroll

April 2, 2026 10:45 PM

Disclaimers: This is a paid advertorial discussing OceansMD, a telehealth platform. It is not independent medical advice, diagnosis, or treatment. Eligibility for prescription therapy is determined by a licensed healthcare provider, and a prescription is not guaranteed. Compounded medications are not FDA-approved finished drugs. Always consult a qualified healthcare professional before starting any prescription weight loss program. This article...

Read more
MaxVitalize Review 2026: Don't Buy Max Vitalize Supplement Before Reading This Report First!
Healthcare & PharmaceuticalAdvertorial

MaxVitalize Review 2026: Don't Buy Max Vitalize Supplement Before Reading This Report First!

April 2, 2026 10:40 PM

Disclaimers: This sponsored article discusses MaxVitalize, a dietary supplement sold through the official MaxVitalize website. This article contains affiliate links. A commission may be earned if you purchase through these links at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. MaxVitalize is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any...

Read more
Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026
Healthcare & PharmaceuticalConferences

Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026

April 2, 2026 7:45 PM

Following the recent FDA Premarket Approval (PMA) of the Synergy Disc®, Todd H. Lanman, MD, a pioneer in motion-preserving spine surgery, will present the first full results from the U.S. Investigational Device Exemption (IDE) clinical trial at the International Society for the Advancement of Spine Surgery (ISASS) 2026 Annual Conference in Miami Beach, April 9-11. Dr. Lanman served as a principal investigator in the multicenter U.S. IDE study...

Read more
Birth Code Oracle Review 2026: Is It Legit or Worth It?
Healthcare & PharmaceuticalAdvertorial

Birth Code Oracle Review 2026: Is It Legit or Worth It?

April 2, 2026 11:50 AM

Disclaimers: This article is a paid advertorial published for informational and entertainment purposes only. It does not constitute professional advice of any kind - including medical, psychological, legal, or financial guidance. Numerology and astrology are belief-based practices rooted in ancient cultural traditions; they are not regulated services and carry no scientific validation as predictive systems. Individual experiences vary widely....

Read more
Black Book Research Releases 2026 State of Digital Healthcare in Post-Acute Care Report as Providers Shift Spending to Reimbursement Protection, Referral Speed, Workforce Stability, and Cyber Resilience
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Releases 2026 State of Digital Healthcare in Post-Acute Care Report as Providers Shift Spending to Reimbursement Protection, Referral Speed, Workforce Stability, and Cyber Resilience

April 2, 2026 11:45 AM

Black Book Research today announced the release of its new Q2 2026 market-intelligence report, 2026 State of Digital Healthcare in Post-Acute Care, a sector-specific analysis of technology buying patterns, market demand, regulatory pressure, operating costs, workforce constraints, financing trends, implementation realities, technology gaps, and vendor landscape coverage across skilled nursing, subacute care, home health, hospice, assisted...

Read more
AGS Health(R) Expands Data Security Portfolio with HITRUST Certification
Healthcare & PharmaceuticalCompany Update

AGS Health(R) Expands Data Security Portfolio with HITRUST Certification

April 2, 2026 9:30 AM

AGS Health®, a leading provider of tech-enabled RCM solutions and a strategic growth partner to healthcare providers across the U.S., announced today it has enhanced its security profile with HITRUST i1 certification for its cloud-hosted and on-premises enterprise infrastructure and SaaS applications, and the systems and platforms that support its global operations. This certification shows that AGS Health has met requirements defined by a...

Read more
Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Healthcare & PharmaceuticalCompany Update

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

April 2, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that it is a silver-level sponsor of the April 2-4, 2026 Annual ELITE PED-GI Congress in Abu Dhabi in the United Arab Emirates (UAE). As previously announced, Napo is supporting an independent investigator-initiated proof-of-concept study of crofelemer liquid formulation in pediatric intestinal failure (IF) patients with in microvillus inclusion...

Read more
AIF Reaches First Close of Fund II Which Will Invest in Solutions Related to Autism, Behavioral Health and Mental Health Conditions
Healthcare & PharmaceuticalCompany Update

AIF Reaches First Close of Fund II Which Will Invest in Solutions Related to Autism, Behavioral Health and Mental Health Conditions

April 2, 2026 9:00 AM

AIF, a pioneering venture capital fund for autism, behavioral health and mental health conditions, has reached the first close of its second fund (Fund II), which will invest in solutions related to autism, behavioral health, mental health and related conditions. Launched in 2021, AIF now has approximately $150 million in assets under management with 17 portfolio companies and two successful exits from Fund I. Since its founding, AIF has...

Read more
A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer
Healthcare & PharmaceuticalEnvironmental, Social and Governance

A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer

April 2, 2026 8:35 AM

Key Takeaways Combatting Home Modality Loss: To help address the 30% of patients who leave peritoneal dialysis (PD)- a home treatment option - within two years of starting treatment, DaVita developed and deployed a predictive AI model that supports clinical teams in identifying patients needs to sustain home dialysis. Closing the Visibility Gap: DaVita's connected cyclers and CWOW system provide care teams with consistent patient updates and...

Read more
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Healthcare & PharmaceuticalCompany Update

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

April 2, 2026 8:30 AM

Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced the Australian Patent Office has accepted its patent application for its topical dermal filler program utilizing its BDS. The patent, entitled "Compositions for the treatment of conditions by dermal fillers," (Australian Patent Application No. 2020315876) continues to strengthen Dermata's global...

Read more
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Healthcare & PharmaceuticalConferences

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care

April 2, 2026 8:10 AM

Developed in collaboration with internationally recognized experts and grounded in peer-reviewed data, the program provided evidence-based updates on recent advances and innovations across key therapeutic areas, underscoring scientific integrity and evidence-based discussions. Beyond the science, the conference brought into focus how effective communication between healthcare professionals and patients can lead to improved diagnostic accuracy,...

Read more
Black Book Recognizes Innovaccer as a 2026 Leader in AI-Powered Revenue Cycle Autonomy and Population Health Data Activation
Healthcare & PharmaceuticalAwards

Black Book Recognizes Innovaccer as a 2026 Leader in AI-Powered Revenue Cycle Autonomy and Population Health Data Activation

April 2, 2026 7:00 AM

Black Book Research has recognized Innovaccer with top-ranked distinction in two 2026 healthcare technology evaluations: AI-Powered Revenue Cycle Autonomy and Population Health Data Integration, Activation & Analytics. Taken together, the findings point to a broader market transition now underway across healthcare operations: buyers are moving beyond reporting-centric tools and isolated automation toward platforms that unify data, orchestrate...

Read more
MedMira Reports Second Quarter Results FY2025
Healthcare & PharmaceuticalEarnings

MedMira Reports Second Quarter Results FY2025

April 1, 2026 10:00 PM

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026. Corporate update In Q2 FY2026, the Company signed a distribution agreement with McKesson, the world's second largest wholesalers in health care. This partnership allows MedMira to reach more customers and benefit from an excellent service and network provided by a leading supplier of medical and surgical products in North America....

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?